Thyrogen is currently available in more than 45 countries. It was first approved in the United States in 1998 for use in patients with well- differentiated thyroid cancer who have had their thyroid ...

The FDA has approved the use of Thyrogen (thyrotropin alfa for injection) to be used in combination with radioiodine to ablate or destroy any remaining thyroid tissue in patients who have had ...

CAMBRIDGE, Mass.-- Nov 13, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that due to the continued progress in its manufacturing operations this year, its supply of ...

CAMBRIDGE, Mass. The Food and Drug Administration has granted expanded approval for Genzyme’s thyroid cancer drug Thyrogen, according to published reports. The new indication allows for Thyrogen ...

Genzyme announced that the FDA has approved the revised prescribing information for Thyrogen (thyrotropin alfa for injection) to expand the dose range of radioiodine (RAI) when used for thyroid ...

Sanofi's ($SNY) biotech unit Genzyme is recalling more than 36,000 vials of its thyroid cancer drug Thyrogen from the U.S., Puerto Rico and four other countries ...

Please provide your email address to receive an email when new articles are posted on . PROVIDENCE, R.I. – A two-week low-iodine diet is necessary for adequate outpatient preparation for 131-I ...

Please provide your email address to receive an email when new articles are posted on . Due to unexpected delays in the release of three lots of thyrotropin alfa for injection intended for both US and ...